ABSTRACT
INTRODUCTION
The Escherichia coli catabolite gene activator protein (CAP; also referred to as the cAMP receptor protein, CRP) is a sequencespecific DNA binding protein involved in transcription regulation; CAP functions by binding, in the presence of the allostenc effector cAMP, to specific DNA sites located at or near promoters (1) (2) (3) . The three-dimensional structure of CAP in complex with cAMP has been determined to 2.5 A resolution by x-ray diffraction analysis (4) . The protein is a dimer of two chemically identical subunits, each of which is 209 amino acids in length and contains a helix-tum-helix DNA binding motif (see refs. 5,6) . A model has been proposed for the alignment of the structure of CAP to the structure of DNA in the CAP-DNA complex (7, 8) . In the model, the CAP-DNA complex is 2-fold symmetric: one subunit of the CAP dimer interacts with one half of the DNA site; the other subunit of the CAP dimer interacts in a 2-fold symmetry related fashion with the other half of the DNA site. One contact between an amino acid of the helix-turn-helix motif of CAP and a base pair of the DNA half site has been identified experimentally (9) (10) (11) : i.e., Glul81 of CAP has been shown to contact base pair 7 of the DNA half site. Substitution of Glul81 by Val or Leu eliminates specificity between G:C, A:T, C:G, and T:A at base pair 7 of the DNA half site.
Two different detailed models have been proposed, listing contacts between amino acids of the helix-tum-helix motif of CAP and base pairs of the DNA half site (10, 13) . We will refer to the model of Weber and Steitz (13; see also ref. 14) as 'model I'; and to the model of Ebright et al. (10;  see also ref. 12) as 'model n.' Figure 1 compares the two models. The most important difference between the two models involves Lysl88 of CAP. Model I predicts that Lysl88 makes a specificity determining contact with base pair 7 of the DNA half site (13); i.e., model I predicts that Lysl88 makes H-bonds with the guanine N7 atom and the guanine O 6 atom of G:C at base pair 7 of the DNA half site. Note that only G:C (not A:T, C:G, or T:A) can make the two putative H-bonds. In contrast, model II predicts that Lysl88 makes no contact with base pair 7 of the DNA half site (10) . The different predicted roles for Lysl88 in the two models are due to essentially arbitrary differences in the side-chain torsion angles used in the model building. (The Lys side chain is long and flexible.) Both models are stereochemicaUy acceptable; it is not possible to choose between the two models by model building.
In this paper, we have tested experimentally the role of Lysl88 in specificity at base pair 7 of the DNA half site. Our approach was to replace Lys 188 by an amino acid unable to contact base pair 7, and, then, to ask whether this replacement affects specificity at base pair 7. This general approach has been designated the 'loss-of-contact approach,' and has been used successfully in investigation of amino acid-base pair contacts by CAP, Lac repressor, X repressor, X cro, AraC protein, and the a subunit of E. coli RNA polymerase (11, 12, (15) (16) (17) (18) (19) .
To eliminate the ability of amino acid 188 to contact a DNA base pair, we have replaced Lys 188 by Asn. We chose Asn for two reasons: First, at position 188 of CAP, the Asn side chain is too short to contact a DNA base pair (in the context of either model I or model II). Second, in four of the eight proteins known from structural studies to contain the helix-turn-helix motif, Asn is the amino acid at the position corresponding to position 188 of CAP (5, 6) ; this suggests that replacement of Lysl88 of CAP by Asn is not likely to disrupt the helix-turn-helix motif. Site-directed mutagenesis was used to construct two substituted CAP variants: [Asnl88]CAP and [Vall81;Asnl88]CAP.
[Asnl88]CAP lacks the putative contact by Lysl88. [Vall81;Asnl88]CAP lacks both the known contact by Glul81-the amino acid previously demonstrated to contact base pair 7 (9-11; see above)-and the putative contact by Lys 188; we reason that the absence of the contact by Glul81 would permit detection of even a slight contribution by amino acid 188 to specificity at base pair 7.
We have measured the specificities of wild-type CAP and of the substituted CAP variants with respect to G:C, A:T, C:G, and T:A at base pair 7 of the DNA half site. DNA binding experiments were performed both in vitro and in vivo.
[Asnl88]CAP exhibited the same specificity at base pair 7 as did wild-type CAP. [Vall81;Asnl88]CAP exhibited the same specificity at base pair 7 as did [Vall81]CAP. These results indicate that Lys 188 makes no contribution to specificity at base pair 7. We propose, contrary to model 1 (13) , that Lys 188 makes no contact with base pair 7. Strains XAE300, XAE371, XAE372, XAE373, XAE374, XAE375, and XAE376 were constructed as follows: Strain XAE13 (Acrp45 strA pcnBSO zad: :TnlO AlacproABXJ 11 argEam metB ara rpoB nal Su2 pHA5) was lysogenized with \i434plac5 and derivatives of \i434plac5 having substitutions at base pairs -66 and/or -57 of lacPl (Table 2) ; lysogens were identified by blue colony color on 5-bromo-4-chloro-3-indolyl-/3-£)-galactoside indicator plates. The resulting lysogens were grown in liquid culture in the absence of ampicillin selection, isolates that had lost plasmid pHA5 were identified by red colony color on maltose-tetrazolium indicator plates. The isolates utilized were established to be single-copy lysogens, based on segregation pattern, and based on the level of CAP-independent /3-galactosidase expression.
MATERIALS AND METHODS

Bacterial Strains
Bacteriophage
A list of bacteriophage used or constructed in this work is presented in Table 2 .
\i434plac5-PlL162 is a derivative of \i434plac5 (15) having the LI62 promoter mutation (J. Beckwith, personal communication); \i434plac5-PlL162 yields colorless plaques on 5-bromo-4-chloro-3-indolyl-/3-D-galactoside indicator plates. Derivatives of \i434plac5 having substitutions at base pairs -66 and/or -57 of lacPJ were constructed by homologous recombination between \i434plac5-PJLJ62 and appropriate M13mp2 derivatives (11, 23, 24 ; method in ref. 26); recombinants were identified by light blue plaque color on 5-bromo-4-chloro-3-indolyl-/9-D-galactoside indicator plates.
Plasmids Encoding CAP and CAP Derivatives
Plasmids pHA5, which encodes wild-type CAP, and pPC181 V, which encodes [Vall81]CAP, have been described previously (11, 27) .
Plasmids encoding [Asnl88]CAP (plasmid pTK188N) and 
TnIO \i434plac5 TnIO \i434plac5-Pl(-66A;-57T) TnIO \i434plac5-Pl(-66C,-57G) TnIO \i434plac5-PI(-6ffT;-57A) .TnIO \i434plac5-PI(-66A) :TnlO \i434plac5-PI(-66Q TnIO \i434plac5-Pl(-66T)
To analyze the profile of specificity of CAP variant X, the plasmid encoding X was introduced into each of the following. XAE300, XAE371, XAE372, XAE373, XAE374, XAE375, and XAE376 (see 
CAP and CAP Derivatives
CAP and CAP derivatives were purified as described in ref. 30 . For each preparation, the fraction of molecules active in sequencespecific DNA binding (0.14 to 0.64) was determined by titration with 5.0 nM pP]-ICAP; all data are reported in terms of molar concentrations of active dimers.
Synthetic DNA Fragments 40 base pair double-stranded DNA fragments containing the consensus DNA site for CAP, or substituted derivatives of the consensus DNA site for CAP (sequences in Figure 2 ), were synthesized, purified, and radiolabelled as described in ref. 8 .
In Vitro DNA Binding Experiments
In vitro DNA binding experiments were performed using the nitrocellulose filter binding technique as described in ref. 8 . The technique yields high-precision data for K D = 1 x 10" l2 M to K D = 1 x 10~7 M (precision of estimate of K D typically within a factor of 1.5 to 2). Where K D > lxlO" 7 M, the value K D = 1 x 10" 7 M was used to calculate a minimum estimate for the ratio
In Vivo DNA Binding Experiments: Experimentation
To analyze the profile of specificity of CAP variant X, the plasmid encoding X was introduced into each of the following: XAE300, XAE371, XAE372, XAE373, XAE374, XAE375, and XAE376. Note that each of the resulting strains was identical except for one base pair, or two base pairs, in lacPl. Therefore, in each of the resulting strains the intracellular concentration of CAP was equal.
For each strain, the differential rate of/3-galactosidase synthesis was determined by the method of Miller (33) . Cultures were 
where Z denotes the measured differential rate of/3-galactosidase synthesis, and Z M denotes the maximum differential rate of j3-galactosidase synthesis. By rearrangement of the equilibrium relationship, it can be shown that (see refs. 12,15,34,35) .
where 
In the present work, Z M was determined by calculation
Z M was calculated using Z, and Z2 for interaction of CAP with DNA sites 1 and 2 as measured in vivo, and K D yK D2 for interaction of CAP with the identical DNA sites 1 and 2 as measured in vitro (data in ref. 11). Z^ was calculated to be 5600 (±500). Estimates of K0/K DP + are not extremely sensitive to the value of Z M .
The technique yields high-precision data for 6 = 0.002 to 9 = 0.95 (precision of estimate of 0 typically within 10%). Where 6 < 0.002, the value 6 = 0.002 was used to calculate a minimum estimate for the ratio
RESULTS
In Vitro DNA Binding Experiments
We have performed equilibrium DNA binding assays using the nitrocellulose filter binding technique in order to determine the profiles of specificity of wild-type CAP, substitutions at base pair 7 of the DNA half site (fragments ICAP7AS, ICAP7CS, and ICAP7TS; sequences in Figure 1A) . The data are presented in Table 3 . The data in Table 3 are expressed as the ratio KD/KDCONS 1 ie , ^ me equilibrium dissociation constant for the interaction of CAP variant X with a substituted DNA site, divided by the equilibrium dissociation constant for the interaction of the identical CAP variant X with the consensus DNA site. The role of Lysl88 is inferred from comparison of the profile of specificity exhibited by wild-type CAP to the profile of specificity exhibited by [Asnl88]CAP, and from comparison of the profile of specificity exhibited [Vall81]CAP to the profile of specificity exhibited by [Vall81;Asnl88]CAP.
Wild-Type CAP and [Asnl88]CAP
Wild-type CAP exhibited K DCONS equal to 2.6 (±0.3)x 10"" M for interaction with the consensus DNA site. Wild-type CAP interacted at least 3000 times more tightly with the consensus DNA site than with the derivatives of the consensus DNA site containing the symmetric A:T, C:G, and T:A substitutions at base pair 7 of the DNA half site. This corresponds to a specificity free energy of at least 4.7 kcal/mol. These results demonstrate that wild-type CAP has robust specificity for G:C at base pair 7 of the DNA half site.
[Asnl88]CAP exhibited KDCONS equal to 3.9 (±0.5)x lO" 10 M for interaction with the consensus DNA site.
[Asnl88]CAP interacted at least 300 times more tightly with the consensus DNA site than with the derivatives of the consensus DNA site containing the symmetric A:T, C:G, and T:A substitutions at base pair 7 of the DNA half site. This corresponds to a specificity free energy of at least 3.3 kcal/mol These results demonstrate that [Asnl88]CAP has the same qualitative profile of specificity at base pair 7 of the DNA half site as does wild-type CAP: i.e., robust specificity for G:C at base pair 7 of the DNA half site. We have also analyzed the profiles of specificity of wild-type CAP and [Asnl88]CAP with respect to base pairs 5 and 6 of the DNA half site. The experiments were performed using as ligands derivatives of the consensus DNA site with the symmetric A:T, CG, and T:A substitutions at base pair 5 of the DNA half site, and derivatives of the consensus DNA site with the symmetric A:T, C:G, and G:C substitutions at base pair 6 of the DNA half site. The results demonstrate that [Asnl88]CAP has the same profile of specificity at base pairs 5 and 6 as does wild-type CAP (data not shown).
In addition to the above experiments, we have performed analogous in vitro DNA binding experiments, using the gelretardation assay technique (11, 36, 37) , and using as ligands a 42 base pair DNA fragment having the wild-type lacPl DNA site for CAP and three 42 base pair DNA fragments having derivatives of the lacPl DNA site for CAP with the symmetric A:T, C:G, and T: A substitutions at base pair 7 of the DNA half site (sequences in Figure 1 
In Vivo DNA Binding Experiments
We have performed quantitative in vivo DNA binding assays in order to confirm the profiles of specificity of wild-type CAP, 'CONS' denotes the consensus DNA site, substituted derivatives of the consensus DNA site are identified by the position and sequence of the substitutions (sequences in Figure 1A ). ' +' denotes the wild-type lacPI DNA site, substituted derivatives of the lacPl DNA site are identified by the position and sequence of the substitutions (sequences in Figure 2 ). The experiments were performed using as ligands the wild-type lacPl DNA site for CAP, three derivatives of the lacPl DNA site for CAP with the symmetric A:T, C:G, and T:A substitutions at base pair 7 of the DNA half site, and three derivatives of the lacPl DNA site for CAP with the single A:T, C:G, and T:A substitutions at base pair 7 of the left DNA half site (sequences in Figure IB) . The data are presented in Tables 4 and 5 . The data in Tables  4 and 5 
Method
We have developed a quantitative in vivo assay technique that enables one to determine the profile of specificity of CAP variant X with respect to the wild-type lacPl DNA site for CAP, and with respect to each of the six substituted derivatives of the lacPl DNA site for CAP illustrated in Figure 26 . The technique uses seven E. coli tester strains: XAE300, XAE371, XAE372, XAE373, XAE374, XAE375, and XAE376 (Table 1) . Each tester strain has three important components: (/) Acrp45, a deletion of the gene that encodes wild-type CAP. Acrp45 is >5 kb in length; it deletes all homology to the 3.5 kb crp insert of the plasmids used in this study (21, 38) .
(if) lacZ, the gene that encodes the assayable product /3-galactosidase. In tester strain XAE300, lacZ is placed under the control of the wild-type lacPl DNA site for CAP; in the remaining six tester strains, lacZ is placed under the control of derivatives of the lacPl DNA site for CAP with the symmetric A:T, C:G, and T:A substitutions at base pair 7 of the DNA half site, or with the single A:T, C:G, and T:A substitutions at base pair 7 of the left DNA half site (sequences in Figure IB) . The lacZ gene is present on a \i434plac5 prophage stably integrated into the bacterial chromosome at att\. (Hi) pcnB80 (22) . The presence of the pcnB80 marker results in a decrease in the copy number of plasmid pBR322 derivatives from approximately 40 copies per cell to approximately 4 copies per cell; this results in an up to 10-fold reduction in the intracellular concentration of proteins encoded by plasmid pBR322 derivatives (22) . The presence of pcnB80 reduces the possibility that a plasmid-encoded CAP variant will be toxic to the cell. In order to analyze the profile of specificity of CAP variant X, the plasmid encoding X is introduced into each of the seven tester strains. This results in the construction of a set of seven strains each having the identical plasmid encoding X (example in Table 1 ). The differential rate of/3-galactosidase synthesis is determined for each strain of the set, and ratios of equilibrium dissociation constants for the interactions of CAP variant X with different DNA sites are calculated as described in Materials and Methods. Note that each strain of one set is identical except for lacPl; one important implication is that in each strain of one set the intracellular concentration of CAP is equal. All calculations are performed using only data from strains within the same set. Therefore, this analysis does not incur complications due to either (0 differing stabilities of substituted vs. wild-type proteins, or (if) differing rates of synthesis of substituted vs. wild-type proteins.
The equilibrium under analysis is C + P(=)CP, where C denotes CAP, P denotes lacPl, and CP denotes the CAP-lacPl complex. The measured differential rate of /3-galactosidase synthesis, Z, is proportional to CP. The maximum differential rate of /3-galactosidase synthesis, Z M (determined independently), is proportional to Ptot (P M = P + CP). Therefore, the occupancy of lacPl, 8, is equal to Z/Z M (equation 1). For two strains in which the intracellular concentration of CAP is equal (e.g., any two strains from within the same set), one can calculate the ratio K D ,/K D2 from the measured values Z, and Z? (
equation 3).
This technique is similar to that used previously to analyze the profile of specificity of Lac repressor and Lac repressor variants (12, 15) . The technique is rapid and simple; most important, the technique enables one to determine the profile of specificity of CAP variant X without purification of the protein. The good agreement between the results of the in vitro DNA binding experiments and the results of this in vivo technique (see below; cf. Tables 3 and 4 ) supports the usefulness of this technique.
Wild-Type CAP and [Asnl88]CAP
Wild-type CAP interacted 800 to at least 1000 times more tightly with the wild-type lacPl DNA site than with the derivatives of the lacPl DNA site containing the symmetric A:T, C:G, and T A substitutions at base pair 7 of the DNA half site. Wild-type CAP interacted 20 to 100 times more tightly with the wild-type lacPl DNA site than with the derivatives of the lacPl DNA site containing the single A:T, C:G, and T:A substitutions at base pair 7 of the left DNA half site. These results confirm that wildtype CAP has robust specificity for G C at base pair 7 of the DNA half site.
[Asn 188]CAP interacted 500 to at least 900 times more tightly with the wild-type lacPl DNA site than with the derivatives of the lacPl DNA site containing the symmetric A:T, C:G, and T A substitutions at base pair 7 of the DNA half site.
[Asnl88]CAP interacted 20 to 100 times more tightly with the wild-type lacPl DNA site than with the derivatives of the lacPl DNA site containing the single A:T, C:G, and T:A substitutions at base pair 7 of the left DNA half site. These results demonstrate that [Asnl88]CAP has exactly the same profile of specificity at base pair 7 of the DNA half site as does wild-type CAP: i.e., robust specificity for G:C at base pair 7 of the DNA half site. [Vall81;Asnl88]CAP interacted essentially equally tightly with the lacPl DNA site and with the derivatives of the lacPl DNA site containing the symmetric A:T, C:G, and T:A substitutions at base pair 7 of the DNA half site; the mean value of K D /K ? p+ was 2. [Vall81;Asnl88]CAP also interacted essentially equally tightly with the wild-type lacPl DNA site and with the derivatives of the lacPJ DNA site containing the single A:T, C:G, and T:A substitutions at base pair 7 of the left DNA half site; the mean value of Kp/Ko P + was 0.6. These results confirm that [Vall81;Asnl88]CAP has the same profile of specificity at base pair 7 of the DNA half site as does [Vall81]CAP: i e., no specificity at base pair 7 of the DNA half site.
DISCUSSION
The results indicate that [Asnl88]CAP has the same specificity at base pairs 5, 6, and 7 of the DNA half site as does wild-type CAP. The results indicate that [Vall81;Asnl88]CAP has the same specificity at base pairs 5, 6, and 7 of the DNA half site as does [Vall81]CAP. Based on these results, we conclude that Lysl88 of CAP makes no contribution to specificity at base pairs 5, 6, and 7 of the DNA half site.
We propose, contrary to model I (Figure M ; ref. 13) , that Lysl88 of CAP does not contact base pair 7 of the DNA half site. This proposal is consistent with the methylation-interference and the depurination-interference data regarding base pair 7 of the DNA half site (39, 40) . Methylation of the guanine N7 atom of base pair 7 of the left half site of the lacPl DNA site for CAP does not detectably affect affinity (39, 40) . Furthermore, complete removal of the guanine base of base pair 7 of the left half site of the lacPl DNA site for CAP does not detectably affect affinity (39) . These methylation-interference and depurinationinterference data suggest that the guanine base of base pair 7 of the DNA half site-the base that Lysl88 is proposed to contact in model I (Figure 1/4 ; ref. 13)-is not involved in an amino acidbase contact.
We propose that Lysl88 of CAP either: (/) makes no contact with DNA, or (if) makes a sequence-independent contact with a DNA phosphate. Model building indicates that formation of a contact between Lysl88 of CAP and the top-strand DNA phosphate 5' to base pair 6 of the DNA half site is stereochemically feasible (8) . In this report, we have observed that substitution of Lysl88 of CAP results in a 20-fold to 30-fold increase in the equilibrium dissociation constant for interaction with the consensus DNA site, K D CONS ; this result is consistent with the existence of a contact between Lysl88 of CAP and DNA in the CAP-DNA complex*. It should be possible, through comparison of the salt-dependences of [Asnl88]CAP-DNA complex formation and CAP-DNA complex formation, to establish definitively whether Lysl88 of CAP makes a contact with a DNA phosphate (see refs. 8,42) .
